ARCTURUS THERAPEUTICS HOLDINGS INC. Capital Expenditures
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) reported Capital Expenditures of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- ARCTURUS THERAPEUTICS HOLDINGS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00.
- ARCTURUS THERAPEUTICS HOLDINGS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ARCTURUS THERAPEUTICS HOLDINGS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was -$88.00K.
- ARCTURUS THERAPEUTICS HOLDINGS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $181.00K, a 126.25% increase year-over-year.
- ARCTURUS THERAPEUTICS HOLDINGS INC. payments to acquire property, plant, and equipment for fiscal 2025 was $230.00K, a 64.51% decline from fiscal 2024.
- ARCTURUS THERAPEUTICS HOLDINGS INC. payments to acquire property, plant, and equipment for fiscal 2024 was $648.00K, a 77.66% decline from fiscal 2023.
- ARCTURUS THERAPEUTICS HOLDINGS INC. payments to acquire property, plant, and equipment for fiscal 2023 was $2.90M, a 62.45% decline from fiscal 2022.
- ARCTURUS THERAPEUTICS HOLDINGS INC. payments to acquire property, plant, and equipment for fiscal 2022 was $7.73M, a 126.83% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | -$88.00K derived: sum of 3 quarters · filed 2026-08-06 | $93.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | -$88.00K derived: sum of 2 quarters · filed 2026-05-07 | $93.00K derived: sum of 3 quarters · filed 2026-05-07 | $93.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $93.00K derived: sum of 2 quarters · filed 2026-03-03 | $93.00K derived: sum of 3 quarters · filed 2026-08-06 | $230.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $181.00K derived: sum of 2 quarters · filed 2026-08-06 | $318.00K 10-Q · filed 2025-11-12 | $318.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $137.00K 10-Q · filed 2026-08-06 | $137.00K derived: sum of 3 quarters · filed 2026-08-06 | $217.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $137.00K 10-Q · filed 2026-05-07 | $137.00K derived: sum of 2 quarters · filed 2026-05-07 | $217.00K derived: sum of 3 quarters · filed 2026-05-07 | $545.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $80.00K derived: sum of 2 quarters · filed 2026-03-03 | $408.00K derived: sum of 3 quarters · filed 2026-03-03 | $648.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $408.00K derived: sum of 2 quarters · filed 2025-11-12 | $648.00K 10-Q · filed 2025-11-12 | $1.52M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $328.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $568.00K 10-Q · filed 2025-08-11 | $1.44M derived: sum of 3 quarters · filed 2026-03-03 | $2.42M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $240.00K 10-Q · filed 2025-05-12 | $1.11M derived: sum of 2 quarters · filed 2026-03-03 | $2.10M derived: sum of 3 quarters · filed 2026-03-03 | $2.45M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $875.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.86M derived: sum of 2 quarters · filed 2026-03-03 | $2.21M derived: sum of 3 quarters · filed 2026-03-03 | $2.90M 10-K · filed 2026-03-03 |
| 2023-09-30 | $981.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.33M derived: sum of 2 quarters · filed 2024-11-07 | $2.03M 10-Q · filed 2024-11-07 | $5.83M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | $354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.04M 10-Q · filed 2024-08-05 | $4.85M derived: sum of 3 quarters · filed 2025-03-06 | $7.04M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | $691.00K 10-Q · filed 2024-05-08 | $4.50M derived: sum of 2 quarters · filed 2025-03-06 | $6.68M derived: sum of 3 quarters · filed 2025-03-06 | $6.31M derived: sum of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | $3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $5.99M derived: sum of 2 quarters · filed 2025-03-06 | $5.62M derived: sum of 3 quarters · filed 2025-03-06 | $7.73M 10-K · filed 2025-03-06 |
| 2022-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.81M derived: sum of 2 quarters · filed 2023-11-14 | $3.92M 10-Q · filed 2023-11-14 | $5.04M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | -$378.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.73M 10-Q · filed 2023-08-07 | $2.85M derived: sum of 3 quarters · filed 2024-03-14 | $4.62M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | $2.11M 10-Q · filed 2023-05-09 | $3.23M derived: sum of 2 quarters · filed 2024-03-14 | $5.00M derived: sum of 3 quarters · filed 2024-03-14 | $5.40M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $2.88M derived: sum of 2 quarters · filed 2024-03-14 | $3.29M derived: sum of 3 quarters · filed 2024-03-14 | $3.41M 10-K · filed 2024-03-14 |
| 2021-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.17M derived: sum of 2 quarters · filed 2022-11-09 | $2.29M 10-Q · filed 2022-11-09 | $2.98M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $404.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $522.00K 10-Q · filed 2022-08-09 | $1.22M derived: sum of 3 quarters · filed 2022-08-09 | $1.65M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $118.00K 10-Q · filed 2022-05-09 | $815.00K derived: sum of 2 quarters · filed 2022-05-09 | $1.25M derived: sum of 3 quarters · filed 2022-05-09 | $1.72M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $697.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.13M derived: sum of 2 quarters · filed 2022-03-01 | $1.60M derived: sum of 3 quarters · filed 2022-03-01 | $1.74M 10-K · filed 2022-03-01 |
| 2020-09-30 | $434.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $903.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.04M 10-Q · filed 2021-11-09 | $1.36M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $469.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $611.00K 10-Q · filed 2021-08-10 | $926.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.08M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $142.00K 10-Q · filed 2021-05-10 | $457.00K derived: sum of 2 quarters · filed 2022-03-01 | $616.00K derived: sum of 3 quarters · filed 2022-03-01 | $882.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $474.00K derived: sum of 2 quarters · filed 2022-03-01 | $740.00K derived: sum of 3 quarters · filed 2022-03-01 | $818.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $159.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $425.00K derived: sum of 2 quarters · filed 2020-11-09 | $503.00K 10-Q · filed 2020-11-09 | $728.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $266.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $344.00K 10-Q · filed 2020-08-10 | $569.00K derived: sum of 3 quarters · filed 2021-03-01 | $822.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $78.00K 10-Q · filed 2020-05-08 | $303.00K derived: sum of 2 quarters · filed 2021-03-01 | $556.00K derived: sum of 3 quarters · filed 2021-03-01 | |
| 2018-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $478.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.48M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $253.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.25M 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $1.00M 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |